Imipenem Supplier-Buyer Network — Trade Flow Analysis

Name: Imipenem Supplier-Buyer Trade Network Dataset — 140+ Indian Exporters, 17+ Importers, 94+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Imipenem supplier network, Imipenem buyers, pharmaceutical export India, Imipenem trade data

TransData Nexus

Imipenem

India Pharmaceutical Trade Intelligence

$33.3M140 Suppliers94 CountriesHS 30049099

ExportsIndia → MEXICO27.2%India → BELGIUM10.0%

ImportsUNITED KINGDOM → India$131.3K UNITED STATES → India$111.3K

#1 Supplier: VENUS REMEDIES

Who Supplies Imipenem? Top Manufacturers & Buyers 2026 — VENUS REMEDIES LIMITED Leads | TransData Nexus | TransData Nexus

1VENUS REMEDIES LIMITED

VENUS REMEDIES LIMITED is the first-largest Imipenem exporter from India, with a market share of 15.5% and a total export value of $5.2M across 194 shipments. Their average shipment value of $26.6K is below the market average of $41.5K, reflecting a high-volume, competitive pricing strategy.

VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• LABORATORIOS JAYOR S A DE C V — $1.8M across 69 shipments (35.4% of this supplier's total exports)

• L J S.A DE CV — $1.1M across 41 shipments (21.0% of this supplier's total exports)

• L J S A D C — $944.6K across 35 shipments (18.3% of this supplier's total exports)

• ASCEND LABORATORIES SPA AVENIDA APOQUINDO — $719.0K across 27 shipments (13.9% of this supplier's total exports)

• S T C — $589.0K across 22 shipments (11.4% of this supplier's total exports)

Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (194 shipments) at a per-shipment value of $26.6K, indicating a broad distribution network with many smaller, regular orders.

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the second-largest Imipenem exporter from India, with a market share of 14.2% and a total export value of $4.7M across 119 shipments. Their average shipment value of $39.8K is below the market average of $41.5K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $1.9M across 47 shipments (39.2% of this supplier's total exports)

• M/S. SUN PHARMACEUTICALS MOROCCO LL — $1.4M across 35 shipments (29.8% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $565.8K across 14 shipments (11.9% of this supplier's total exports)

• M/S. HAPHARCO J.S.C BRANCH — $490.1K across 12 shipments (10.4% of this supplier's total exports)

• M/S. HAPHARCO J.S.C BRANCH — $412.1K across 10 shipments (8.7% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (119 shipments) at a per-shipment value of $39.8K, indicating a broad distribution network with many smaller, regular orders.

3SWISS PARENTERALS LIMITED

SWISS PARENTERALS LIMITED is the third-largest Imipenem exporter from India, with a market share of 6.3% and a total export value of $2.1M across 9 shipments. Their average shipment value of $232.9K is above the market average of $41.5K, suggesting premium or bulk contract pricing.

SWISS PARENTERALS LIMITED serves 5 named buyers in our database. BANK OF CEYLON is the dominant customer, accounting for 55.9% of this supplier's tracked business. Top customers include:

• BANK OF CEYLON — $1.2M across 5 shipments (55.9% of this supplier's total exports)

• TO THE ORDER — $714.1K across 3 shipments (34.1% of this supplier's total exports)

• TO THE ORDER OF . — $80.4K across 0 shipments (3.8% of this supplier's total exports)

• TO THE ORDER OF . — $73.1K across 0 shipments (3.5% of this supplier's total exports)

• TO THE ORDER OF . — $56.3K across 0 shipments (2.7% of this supplier's total exports)

Key Insight: SWISS PARENTERALS LIMITED's per-shipment value of $232.9K is 461% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.

4SUN PHARMACEUTICAL INDUSTRIES LTD

SUN PHARMACEUTICAL INDUSTRIES LTD is the fourth-largest Imipenem exporter from India, with a market share of 3.3% and a total export value of $1.1M across 15 shipments. Their average shipment value of $74.2K is above the market average of $41.5K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• M S RANBAXY PHARMACEUTICALS PTY LTD — $425.2K across 6 shipments (38.2% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $265.3K across 4 shipments (23.8% of this supplier's total exports)

• M/S. SUN PHARMACEUTICALS MOROCCO LL — $241.0K across 3 shipments (21.7% of this supplier's total exports)

• JDS CO LTD — $91.2K across 1 shipments (8.2% of this supplier's total exports)

• MS JDS CO LTD — $90.3K across 1 shipments (8.1% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $74.2K is 79% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.

5PROTECH BIO SYSTEMS PRIVATE LIMITED

PROTECH BIO SYSTEMS PRIVATE LIMITED is the fifth-largest Imipenem exporter from India, with a market share of 2.9% and a total export value of $959.8K across 19 shipments. Their average shipment value of $50.5K is above the market average of $41.5K, suggesting premium or bulk contract pricing.

PROTECH BIO SYSTEMS PRIVATE LIMITED serves 2 named buyers in our database. PHARMEDIC SA is the dominant customer, accounting for 97.4% of this supplier's tracked business. Top customers include:

• PHARMEDIC SA — $934.4K across 18 shipments (97.4% of this supplier's total exports)

• DONY TRIUMPH AND CO. — $25.4K across 1 shipments (2.6% of this supplier's total exports)

Key Insight: PROTECH BIO SYSTEMS PRIVATE LIMITED's per-shipment value of $50.5K is 22% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.

6M J BIOPHARM PRIVATE LIMITED

M J BIOPHARM PRIVATE LIMITED is the fifth-largest Imipenem exporter from India, with a market share of 2.1% and a total export value of $713.1K across 9 shipments. Their average shipment value of $79.2K is above the market average of $41.5K, suggesting premium or bulk contract pricing.

M J BIOPHARM PRIVATE LIMITED serves 4 named buyers in our database. LIFELINE CO LIMITED is the dominant customer, accounting for 81.7% of this supplier's tracked business. Top customers include:

• LIFELINE CO LIMITED — $582.8K across 7 shipments (81.7% of this supplier's total exports)

• LIFELINE CO LTD — $82.1K across 1 shipments (11.5% of this supplier's total exports)

• S GENERIX PHARMA DIS — $30.7K across 0 shipments (4.3% of this supplier's total exports)

• S GENERIX PHARMA DIS — $17.5K across 0 shipments (2.5% of this supplier's total exports)

Key Insight: M J BIOPHARM PRIVATE LIMITED's per-shipment value of $79.2K is 91% above the market average of $41.5K, consistent with large-order contracts or value-added formulations.

1Mexico

Mexico ranks as the first-largest destination for Imipenem imports from India, with a total trade value of $9.1M across 20 shipments — representing a 27.2% share of all Imipenem exports. The average shipment value of $453.4K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.

Named Imipenem importers in Mexico: LABORATORIOS JAYOR S.A. DE C.V. is the largest buyer, accounting for 39.6% ($3.6M) of this market's total imports.

• LABORATORIOS JAYOR S.A. DE C.V. — $3.6M (39.6% of Mexico's total)

• LABORATORIOS JAYOR S A DE C V — $1.8M (20.2% of Mexico's total)

• L J S.A DE CV — $1.1M (12.0% of Mexico's total)

Key Insight: Mexico's per-shipment average of $453.4K (992% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Mexico is a key market for Imipenem imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Imipenem imports from India, with a total trade value of $3.3M across 38 shipments — representing a 10.0% share of all Imipenem exports. The average shipment value of $88.0K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Imipenem importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 66.0% ($2.2M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $2.2M (66.0% of Belgium's total)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $831.1K (24.8% of Belgium's total)

Key Insight: Belgium's per-shipment average of $88.0K (112% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Imipenem imports from India.

Primary Market

Secondary Market

3Sri Lanka

Sri Lanka ranks as the third-largest destination for Imipenem imports from India, with a total trade value of $2.5M across 2 shipments — representing a 7.4% share of all Imipenem exports. The average shipment value of $1.2M is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Imipenem importers in Sri Lanka: BANK OF CEYLON is the largest buyer, accounting for 47.4% ($1.2M) of this market's total imports.

• BANK OF CEYLON — $1.2M (47.4% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $1.2M (2878% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Imipenem imports from India.

Primary Market

Secondary Market

4Morocco

Morocco ranks as the fourth-largest destination for Imipenem imports from India, with a total trade value of $2.5M across 17 shipments — representing a 7.4% share of all Imipenem exports. The average shipment value of $144.6K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Imipenem importers in Morocco: M/S. SUN PHARMACEUTICALS MOROCCO LL is the largest buyer, accounting for 57.3% ($1.4M) of this market's total imports.

• M/S. SUN PHARMACEUTICALS MOROCCO LL — $1.4M (57.3% of Morocco's total)

• MS SUN PHARMACEUTICALS MOROCCO LL — $548.3K (22.3% of Morocco's total)

Key Insight: Morocco's per-shipment average of $144.6K (248% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Morocco is a key market for Imipenem imports from India.

Primary Market

Secondary Market

5Myanmar

Myanmar ranks as the fifth-largest destination for Imipenem imports from India, with a total trade value of $2.0M across 4 shipments — representing a 6.0% share of all Imipenem exports. The average shipment value of $502.6K is above the global average of $41.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Imipenem importers in Myanmar: LIFELINE CO LIMITED is the largest buyer, accounting for 29.0% ($582.8K) of this market's total imports.

• LIFELINE CO LIMITED — $582.8K (29.0% of Myanmar's total)

Key Insight: Myanmar's per-shipment average of $502.6K (1110% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Myanmar is a key market for Imipenem imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Imipenem.
2.Flow Mapping: 140 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 803 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 94 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

803 Verified Shipments

140 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Imipenem

Imipenem

Who Supplies Imipenem? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Imipenem? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Imipenem Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1VENUS REMEDIES LIMITED

2SUN PHARMACEUTICAL INDUSTRIES LIMITED

3SWISS PARENTERALS LIMITED

4SUN PHARMACEUTICAL INDUSTRIES LTD

5PROTECH BIO SYSTEMS PRIVATE LIMITED

6M J BIOPHARM PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Imipenem Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Imipenem Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Mexico

2Belgium

3Sri Lanka

4Morocco

5Myanmar

People Also Ask — Imipenem Supplier & Trade Network

Imipenem Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology